Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

BXP, Inc.

BXP

FAVORABLE

May 27, 2026

Research Conclusion

BUY at ~$58.50. BXP is the premier US office REIT trading at 8.4x FFO and ~20-25% NAV discount — distressed valuation for premier CBD properties in Boston, NYC, DC, SF, and LA. The September 2024 dividend cut from $3.92 to $3.20 created the entry point; the 5.5% yield is now sustainable. Price/Worth Fair Value of $76 (+30%) with base case including 290 Binney St life science campus contribution and occupancy recovery to 89%+ by FY2027. Combined with 5.5% dividend yield, the base case implies ~50% three-year total return.

Company Overview & Moat Assessment

BXP, Inc. (formerly Boston Properties) is the largest premier office REIT in the US, with a $20B+ portfolio concentrated in five gateway markets: Boston, New York, Washington DC, San Francisco, and Los Angeles. FY2025 revenue was $3.48B with FFO/share of $6.85, marking a third consecutive annual decline due to post-COVID office weakness. The portfolio is dominated by trophy CBD properties in top submarkets. Active development pipeline of ~$1B includes 290 Binney Street (Boston life science campus) and 343 Madison Avenue (NYC trophy). Portfolio occupancy is ~86% vs. 92% pre-COVID, with management targeting 89%+ by YE 2027. The September 2024 dividend cut from $3.92 to $3.20/yr provides AFFO coverage with margin.

▲ Bull Case

  • ◆Occupancy recovers to 89%+ by FY2027 driven by AI tenant absorption and flight-to-quality: national office leasing volume in Q3 2025 was the highest since 2019; AI companies absorbing SF vacancy; tenants consolidating to trophy properties; multi-tenant ground-up occupancy gains $0.40–0.60/share FFO uplift.
  • ◆290 Binney St + 343 Madison + Reston Next contribute combined $0.40–0.50/share by FY2028: life science development at 290 Binney is pre-leased; 343 Madison anchor lease in 2027 adds NYC trophy revenue; Reston Next continues to contribute.
  • ◆Rate normalization and multiple re-rate to 12–13x FFO: 10-yr Treasury falls to 4.0% or below; cap rates compress; office sentiment improves; multiple re-rates driving stock to $90–100.

▼ Bear Case

  • ◆SF occupancy falls below 75% with major tenant non-renewal: AI absorption fails to materialize; tech tenants further reduce footprint; FFO impact of -$0.30+/share; multiple stays compressed.
  • ◆10-yr Treasury at 5.5%+; cap rate expansion to 7.5–8%: NAV declines to $58/share or below; refinancing on worse terms; FFO compressed; dividend at risk.
  • ◆Second dividend cut announced: yield investors exit; multiple compresses to 6–7x; stock falls to $40–50; AFFO coverage breaks down.
Primary Debate on Wall Street

“The core debate is whether office real estate is structurally impaired due to permanent work-from-home adoption or merely cyclically weak with a recovery ahead. BXP's premier portfolio is the cleanest expression of the 'office bottoms' thesis — if trophy CBD assets recover, BXP is the primary beneficiary; if structural impairment persists, even the highest-quality assets face sustained multiple compression.”

Top Catalysts
  • ◆290 Binney St FFO contribution beginning Q2–Q3 2026 ($0.05–0.06/share quarterly)
  • ◆Q2 2026 leasing volume exceeding 1.3M sf as a sentiment re-rating trigger
  • ◆Portfolio occupancy reaching 89% by YE 2026 or 2027
  • ◆343 Madison Avenue anchor lease signed in 2027 signaling NYC trophy demand
  • ◆Dividend increase announcement post-89% occupancy achievement
Top Risks
  • ◆SF occupancy falling below 75% — MEDIUM probability, HIGH impact; bear case materializes
  • ◆10-yr Treasury sustained at 5.5%+ — LOW-MEDIUM probability, HIGH impact; cap rate expansion impairs NAV
  • ◆Major tenant non-renewal in NYC or Boston — MEDIUM probability, MEDIUM impact; FFO decline
  • ◆Second dividend cut — LOW-MEDIUM probability, HIGH impact; yield investors exit and multiple compresses
  • ◆Permanent structural impairment of office class — MEDIUM probability, HIGH impact; secular thesis worsens

Full Memo Continues

5 more sections, locked

  • ●
    Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • ●
    Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • ●
    Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • ●
    Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • ●
    Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/BXP/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.